Transform a life today.
Genetic testing could mean a new world of personalised treatment that transforms lives. By understanding more about each person’s genes, we will understand more about their epilepsy and how to treat it.
We are Epilepsy Society. The UK’s only charity transforming the lives of people with epilepsy through world-leading research, advocacy and care.
Leading care provider
Our range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Cutting edge research
Epilepsy Society's Chalfont Centre is unique in bringing together intellectual capital to form a powerhouse multidisciplinary team who contribute to a wide ranging spectrum of research.
Epilepsy Support
Our confidential epilepsy helpline and online information give help and support to people who are affected by epilepsy.
Advocacy
We are a voice for people with epilepsy, striving to push epilepsy up the political agenda and bring about change at government level.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Campaigns
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online trolling, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
Latest news
Me & My Shadow: putting patients first
It was a "transformative" day for 26-year-old epilepsy advocate Lucy as she spent time shadowing the Patient Safety Commissioner in the heart of Westminster.
Me & My Shadow: a day with an MP
It was a very different type of dress-down Friday for 19-year-old Nicole Creasey last week, as she donned a neon jacket, goggles and hard hat to tour a National Grid site with Caroline Nokes MP.
Sanofi reports issues around safety study into valproate
New prescribing practices for valproate were introduced in December last year, after a safety study suggested there could be risk of harm for babies through paternal exposure pre-conception. Now the drug manufacturer says there are issues with the safety study and that further analysis is necessary.
It is important never to stop taking valproate – or any medication – without consulting your doctor.
Heat alert – how to stay cool
A heat-health alert has been issued for parts of England for this weekend, with temperatures predicted to reach 30C/86F in London, the Midlands and eastern and southern England.
Me & My Shadow: "science is vital"
It's not every day that an 18-year-old gets to spend time with leading scientists and cutting edge researchers, but Monday 22nd May was one such day.
Me & My Shadow 2023
We're pleased to announce that our Me and My Shadow scheme is back by popular demand - and appropriately enough, we're launching it in National Epilepsy Week.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
We're open:
Monday and Wednesday - 9am to 7.30pm
Tuesday, Thursday, and Friday - 9am to 4pm
Saturday - 9am to 12.30pm
You can also reach us by email
helpline@epilepsysociety.org.uk.